Skip to main content

Good Sense Effervescent Antacid and Pain Relief

NDC 50804-421 · Good Sense

Generic nameAspirin, Citric Acid, Sodium Bicarbonate
Dosage formTABLET, EFFERVESCENT
RouteORAL
Active ingredient(s)ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, ASPIRIN
Strength1000; 325; 1916 mg/1; mg/1; mg/1
Pharmacologic classAcidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

50804-421-36 — 18 POUCH in 1 CARTON (50804-421-36) / 2 TABLET, EFFERVESCENT in 1 POUCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50228-364 — Omeprazole and Sodium Bicarbonate, 50268-182 — SODIUM CITRATE and CITRIC ACID MONOHYDRATE, 50268-183 — SODIUM CITRATE and CITRIC ACID MONOHYDRATE, 50269-005 — ASPIRIN, 50269-006 — ASPIRIN, 50269-158 — ACETAMINOPHEN, ASPIRIN, CAFFEINE, 50269-307 — ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE, 50332-0139 — ASPIRIN, 50332-0144 — Aspirin, Acetaminophen, Caffeine, 50804-157 — Aspirin, 50804-422 — Aspirin, 50804-873 — Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate, 50804-880 — ASPIRIN, 50844-157 — Aspirin, 50844-218 — Aspirin, 50844-254 — Aspirin, 50844-258 — Acetaminophen, Aspirin, Caffeine, 50844-413 — Aspirin, Caffeine, 50844-600 — Aspirin, 50844-675 — Aspirin, +958 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels